4.6 Article

Synthesis, structure, X-ray photoelectron spectroscopy (XPS), and antimicrobial, anticancer, and antioxidant activities of Co (III) complexes based on the antihypertensive hydralazine

期刊

APPLIED ORGANOMETALLIC CHEMISTRY
卷 36, 期 3, 页码 -

出版社

WILEY
DOI: 10.1002/aoc.6565

关键词

antimicrobial; antioxidants; Co (III) complexes; cytotoxicity; hydralazine

向作者/读者索取更多资源

This study synthesized four cobalt (III) complexes and evaluated their antimicrobial, anticancer, and antioxidant activities. Complex 4 exhibited the highest cytotoxicity against lung carcinoma cells and the best antioxidant activity.
The antimicrobial, anticancer, and antioxidant activities of four cobalt (III) complexes, [CoL2]X (X = ClO4 over bar (1); OAc over bar (2), Cl over bar (3), or NO3 over bar (4) with hydralazine Schiff base derivative (HL), were presented. The structure of the newly synthesized complexes 1 and 2 was confirmed utilizing FTIR, UV-Vis, and NMR (H-1 and C-13) spectroscopy. In addition, single crystal X-ray diffraction was used to approve the structure of complex 1. Based on Hirshfeld analysis, the molecular packing of 1 is controlled by short H(sic)H, O(sic)H, N(sic)H, and H(sic)C(pi) interactions. The results of the X-ray photoelectron spectroscopy (XPS) for the Co (III) complexes revealed the characteristic peaks of Co-2p3/2 and Co-2p1/2 with binding energy differences of 14.85-14.96 which greatly approved that the Co (III) complexes have been assembled successfully. Complex 4 (IC50 = 14.97 +/- 0.59 mu g/ml) has the highest cytotoxicity against lung carcinoma A-549 cell line compared to the rest of the Co (III) complexes and the free ligand as well. Also, complex 4 has the best antioxidant activity with IC50 of 283.4 +/- 12.3 mu g/ml. The free ligand has broad spectrum of antibacterial and antifungal actions, while the studied Co (III) complexes have good antibacterial activity especially the chloride complex 3.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据